Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
|PO-GePV-T-38||Probability of Radiation Induced Maculopathy and Optic Neuropathy Following I-125 Eye Plaque Brachytherapy|
M Studenski1*, V Peters2, A Gurayah2, W Jin1, D Kwon3, W Zhao3, Z Correa4, J Harbour5, S Samuels1, (1) Department of Radiation Oncology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, (2) University Of Miami Miller School Of Medicine, Miami, FL, (3) Department of Biostatistics and Bioinformatics, University Of Miami Miller School Of Medicine, Miami, FL, (4) Department of Ophthalmology, University of Miami Bascom Palmer Eye Institute, Miami, FL, (5) Department of Ophthlmology, UT Southwestern Medical Center, Dallas, TX
|PO-GePV-T-39||Dose Reduction and Tumor Coverage in Small Uveal Melanoma Tumors Treated with Eye Plaque Brachytherapy When Normalizing to An Alternative Prescription Point|
S Tan*, E Schnell, D Zuro, S Ahmad, S Martinez, University of Oklahoma Health Sciences Center, Oklahoma City, OK
|SU-K-207-7||Dose Distribution with a High-Z Intraocular Shield-Ferrofluid System: An I-125 Eye Plaque Brachytherapy Monte Carlo Study|
C Oare*, B Gerbi, C Ferreira, University of Minnesota, Minneapolis, MN
|TU-I345-IePD-F5-5||Radio-Luminescent Imaging for Rapid, High Resolution Eye Plaque Loading Verification|
W Liu1, P De Jean2, H Yan3*, E Grafil2, M Ashraf1, T Niedermayr1, M Astrahan4, P Mruthyunjaya1, B Beadle1, L Xing1, (1) Stanford University, Stanford, CA, (2) Luca Medical Systems Inc., Palo Alto, CA, (3) Capital Medical University, Beijing, 11, CN, (4) Eye Plaque Inc, Los Alamitos, CA